AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2010
May 11, 2010
284_dirs_2010-05-11_8daf85ca-f282-48ef-a47a-219a8908f602.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2010-05-07
Reporting Person: Heller Bridgette P (Exe.VP & Pres.Con.Hlth.Care)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-07 | Restricted Stock Unit | $ | A | 29860 | Acquired | 2013-05-07 | Common Stock (29860) | Direct |
| 2010-05-07 | Stock Option (right to buy) | $33.49 | A | 60024 | Acquired | 2020-05-06 | Common Stock (60024) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F2: The option vests in three equal annual installments beginning May 7, 2011.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30